The circadian clock governs ∼24-hour cycles in physiology through rhythmic control of tissue-specific sets of clock-controlled genes (CCGs), which allows precise orchestration of organ function ([@b1]). In mammals (including humans), the circadian system is organized in a hierarchical manner. The suprachiasmatic nuclei of the hypothalamus receive information from external time cues (predominantly, the light/dark cycle) and synchronize peripheral clocks in most major body organs through neuronal or systemic factors ([@b2]--[@b3]). The molecular basis of the circadian clock relies on the rhythmic activity of evolutionarily conserved clock genes and proteins, including those for transcriptional activators (*Clock*/*Npas2* and *Bmal1*), transcriptional repressors (*Per1/2* and *Cry1/2*), and nuclear hormone receptors (*Nr1d1/2* \[Rev-Erbα/β\] and *Rora/Rorg*) ([@b1]). This transcriptional--translational feedback loop controls expression of downstream CCGs to regulate tissue-specific physiology. Disruption of the circadian rhythm (attributable to, for example, effects of aging or shift work) has been correlated with an increased risk of various human diseases, including obesity, diabetes, cardiovascular disease, and cancer ([@b4]).

Articular cartilage is a specialized load-bearing tissue comprising an abundant extracellular matrix, which is produced and maintained by a sparse population of chondrocytes. As the only cell type residing in this tissue, chondrocytes have a poor capacity for endogenous repair, and there is little evidence of cell division throughout adult life ([@b5]). Deterioration in chondrocyte function and survival accompanies the damage and loss of cartilage, a common outcome in degenerative and inflammatory joint diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA).

Several physiologic processes in cartilage exhibit diurnal variation, including the processes of matrix synthesis, the growth rate in the growth plate, and mineralization ([@b6],[@b7]). Mice with mutations in clock genes show altered regulation of bone volume ([@b9]), retarded long bone growth ([@b10]), and increased susceptibility to inflammatory arthritis ([@b11]), providing in vivo evidence for the importance of the molecular clock in the skeletal system. Moreover, in patients with OA and those with RA, there is a clear circadian rhythm in the severity of pain and stiffness and the extent of manual dexterity ([@b12]--[@b13]). Expression of clock genes has been shown in bone and joint tissues ([@b11],[@b14]) and in isolated chondrocytes ([@b10]--[@b16]), but no studies have directly examined the detailed mechanisms, inputs, or targets of the cartilage circadian clock, and none have examined how the clock changes during aging and in the pathogenesis of joint disease.

In the present study, we demonstrate the presence of self-sustained, functional circadian clocks in mouse cartilage tissue, primary chondrocytes, and a human chondrosarcoma cell line. Circadian transcriptome profiling revealed rhythmic expression of ∼3.9% of the genes expressed in mouse cartilage, including key genes associated with tissue homeostasis. In addition, circadian rhythms in the cartilage from aged mice were significantly dampened. Finally, the expression of key circadian clock genes was altered in articular cartilage from mice with experimentally induced OA. Taken together, our results implicate chondrocyte circadian clocks as a key regulator of cartilage homeostasis, and suggest that changes in circadian regulation may play a role in the pathogenesis of joint disease.

MATERIALS AND METHODS
=====================

Animals
-------

All animal studies were performed in accordance with the 1986 UK Home Office Animal Procedures Act. Approval was provided by local ethics review or by the Murdoch Children\'s Research Institute Animal Ethics Committee.

PER2::luc mice carry the firefly luciferase gene fused in-frame with the 3′ end of the *Per2* gene, creating a fusion protein reporter ([@b17]). *ClockΔ19* mice harbor a deletion in exon 19 of the *Clock* gene ([@b18]), producing a dominant-negative mutant protein. *ClockΔ19* mice were crossed onto a PER2::luc background. All mice were bred in-house at the University of Manchester. In addition, 6-week-old male C57BL/6J wild-type (WT) mice were purchased from Harlan Laboratories for use in the time-course microarrays.

Cartilage cultures and bioluminescence recording
------------------------------------------------

Cartilage cultures from PER2::luc mice were prepared by dissection of the cartilaginous portion of the xiphoid process, by dissection of the femoral head cartilage from 6--10-day-old mice, or by scalpel microdissection of the articular cartilage from the femoral condyle and tibial plateau surfaces of 4.4-month-old mice. Cartilage was cultured on 0.4-μm cell culture inserts (Millipore), and bioluminescence was recorded in real time using photomultiplier tube (PMT) devices ([@b19]) or a LumiCycle apparatus (Actimetrics). Baseline subtraction was carried out using a 24-hour moving average. The circadian period was calculated using LumiCycle analysis software (Actimetrics) or using the RAP algorithm ([@b19]). Cultures were also visualized using a self-contained Olympus Luminoview LV200 microscope and recorded using a cooled Hamamatsu ImageEM C9100-13 EM-CCD camera. Images were obtained every hour for 6 days, and results were combined in ImageJ.

For temperature entrainment studies, xiphoid tissues were cut into halves and cultured under PMT recorders in separate incubators at 37°C. After 4 days, alternating 12-hour square-wave temperature cycles of 38.5°C/36°C were applied; the temperature protocols of the 2 incubators were in antiphase. After 3 full temperature cycles, cultures were returned to 37°C. For temperature compensation studies, xiphoid cultures were incubated under PMT devices at a constant temperature of 29°C, 32°C, 37°C, and 39°C (n = 3, n = 4, n = 7, and n = 3, respectively). The mean period (p) was determined at each temperature (T). The frequency (reaction rate \[R\]) was calculated as 1/p, and the temperature coefficient (Q~10°~) was worked out using the following equation: Q~10°~ = (R~2~/R~1~)†10/(T~2~ − T~1~).

Aged animals
------------

Male PER2::luc mice were aged to 20--24 months (n = 10) under a 12-hour light/dark cycle. Young control mice were aged to ∼2--4 months (n = 7). Animals were transferred into a state of constant darkness for 20 days. All animals were killed in the dark at their individual 12-hour cull time (CT12) (i.e., predicted onset of activity for each animal). Amplitude was calculated as the peak-trough difference in bioluminescence of the second peak, with subtraction of baseline data. A minimum of 3 peaks were used to determine the circadian period. Phase was determined by plotting the time at which the first peak occurred in culture, relative to CT12. For dexamethasone treatment, a final concentration of 100 n*M* was applied directly to the recording medium. Amplitude was calculated from the second peak posttreatment.

Histology
---------

Xiphoid cartilage was fixed for 24 hours in 4% paraformaldehyde, followed by decalcification in 0.8*M* EDTA (pH 7.4). Tissue was embedded in wax blocks prior to sectioning and hematoxylin and eosin staining using a Shandon Varistain 24-4 automated staining system.

Time-series microarrays
-----------------------

C57BL/6J mice were entrained to a 12-hour light/dark cycle before release into constant darkness for 39 hours prior to collection of xiphoid cartilage. Tissues were collected every 4 hours, commencing at CT3, for 40 hours. Tissue was pooled (5 animals per pooled sample, 3 samples per time point) and snap frozen in liquid nitrogen. One sample per time point was used for microarray; the remainder of the samples were used for quantitative reverse transcription--polymerase chain reaction (qRT-PCR) validation.

Frozen tissue was disrupted using Mikro-Dismembrator S (Satorius Stedim Biotech). Extraction of RNA was carried out using RNeasy Fibrous Tissue Mini/Micro kits (Qiagen). Affymetrix Mouse430_2 GeneChips were run according to the manufacturer\'s instructions. Technical quality control and outlier analysis were performed using Affymetrix dChip software (version 2005). Background correction, quantile normalization, and gene expression analysis were performed using robust multiarray average. Raw data were deposited in Array Express (accession no. E-MEXP-3780). Genes with an average expression \>2 SD higher than the mean background of all GeneChips were classified as expressed. CircWave Batch version 5 (provided by Dr. Roelof Hut, University of Groningen) was used to fit a sine-wave with 24-hour periodicity to each gene expression data set. The local false discovery rate was calculated using the fdrtool in the R program (results available from the corresponding author upon request) ([@b20]).

Using known clock genes as a guide, a cutoff point of q \< 0.1 was arbitrarily assigned to determine circadian gene expression. JTKCycle ([@b21]) was also used to identify circadian transcripts. A Bonferroni-adjusted *P* value of 0.05 was arbitrarily set as the cutoff for significance. Functional annotation analysis was carried out on overlapping genes, using DAVID algorithms. To model the data for clustering, we used a Gaussian process model ([@b22]). To perform clustering, we specified a statistical model based on a Dirichlet process, a mixture of Gaussian processes ([@b23]), solved using approximate Bayesian inference (based on the approach described in ref.[@b24]). This allowed joint inference of clustering (i.e., which genes belong to which periodic function), alongside inference of the functions themselves. Validation of time-series arrays was carried out using TaqMan-based qRT-PCR (a list of the primers/probes used is shown in Supplementary Table 2, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract>), with results normalized to the values for *β-actin* expression, using the method.

Primary chondrocyte culture
---------------------------

Cells were prepared from 5-day-old PER2::luc mice as described previously ([@b25]). Briefly, cartilage was dissected from the femoral heads, femoral condyles, and tibial plateaus of one litter of mice and sequentially digested in collagenase D solution (Roche) at 3 mg/ml and then 0.5 mg/ml. Cells were seeded directly into 35-mm recording dishes and grown until 90--100% confluent, prior to synchronization and PMT recording or RNA extraction (as described below). The chondrocyte phenotype was confirmed using immunofluorescence against type II collagen (Abcam catalog no. ab54236, with an Alexa 488--conjugated donkey anti-mouse antibody) and by staining of glycosaminoglycans in the extracellular matrix using 1% weight/volume Alcian blue 8GX.

SW-1353 cell culture and lentiviral transduction
------------------------------------------------

The SW-1353 cells used herein constitutively overexpress *Sox9* to drive *Col2a1* expression and maintain a chondrocyte-like phenotype. For time-course experiments, confluent cells were synchronized with 100 n*M* dexamethasone for 1 hour. Samples were collected 24 hours postsynchronization. RNA samples were prepared using the RNeasy Mini kit (Qiagen). Gene expression was analyzed by TaqMan qRT-PCR (a list of the primers/probes used is shown in Supplementary Table 2, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract>), with results normalized to the values for GAPDH using the method. For lentiviral transduction, fragments of the mouse *Per2* (−418 bp) and *Bmal1* (−649 bp) promoters driving luciferase reporters in lentiviral transfer vectors ([@b19]) were cotransfected with lentiviral packaging plasmids into HEK 293FT packaging cells. Virus particles were concentrated in Vivaspin 20 columns (Satorius Stedim Biotech) and applied to cells prior to synchronization and subsequent PMT recording.

Induction of experimental arthritis
-----------------------------------

OA was induced in 10-week-old male C57BL/6 WT mice by destabilization of the medial meniscus (DMM) of the right knee ([@b26]), with sham operation of the left knee as a control. Animals were killed at 1, 2, and 6 weeks after surgery (n = 4 animals with sham/DMM-operated knees per time point). Tibial epiphyses were isolated, placed in RNALater (Ambion) containing 20% ETDA, and decalcified at 4°C for 72 hours. Total RNA was extracted from pooled laser-microdissected sections using TRIzol reagent (Invitrogen) and linearly amplified in 2 rounds using the MessageAmp aRNA kit (Ambion).

Labeled RNA was hybridized to duplicate whole-genome microarrays (G4122A; Agilent). Raw data were processed in R statistical language, using the limma package. Data were adjusted for multiple testing using Benjamini and Hochberg\'s method to control the false discovery rate. Raw data have been deposited in the Gene Expression Omnibus database ([@b26]). Microarrays were validated by SYBR Green qRT-PCR (a list of the primers used is shown in Supplementary Table 3, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract>), using the comparative C~t~ method. Data were normalized to the geometric mean expression values for 2 housekeeping genes, *Atp5b* and *Rpl10*.

RESULTS
=======

An intrinsic molecular circadian clock in cartilage
---------------------------------------------------

To investigate circadian rhythms in cartilage tissue, we monitored the dynamics of PER2::luc protein expression ex vivo in xiphoid (adult mouse) cartilage and femoral head (6-day-old mouse) cartilage from PER2::luc reporter mice, using bioluminescence photon counting. This revealed robust circadian oscillations in both types of cartilage (period ∼24.5 hours), which persisted for 1--3 weeks ([Figures 1](#fig01){ref-type="fig"}A and B). (Further details are available from the corresponding author upon request.) Treatment of cartilage samples (n = 3) with 100 n*M* dexamethasone (a known synchronizer of peripheral clocks) immediately reinitiated a robust rhythm (*P* = 0.018 versus untreated control) ([Figure 1](#fig01){ref-type="fig"}A).

![Evidence of an autonomous circadian clock in mouse cartilage tissue. A, Representative bioluminescence traces (in counts per second) in cultures of xiphoid cartilage (mean ± SD period 24.67 ± 0.13 hours; n = 7) and articular cartilage from the femoral head (mean ± SD period 23.7 ± 0.6 hours; n = 4) of PER2::luc mice. Arrow indicates the time of treatment with 100 n*M* dexamethasone. B, Hematoxylin and eosin (H&E) staining (left) and high-sensitivity EM-CCD camera images (right) of xiphoid tissue. Left, A representative H&E--stained tissue section demonstrates typical morphologic features of the xiphoid cartilage (first panel; bar = 500 μm). The second panel is a higher-magnification view of the boxed area in the first panel (bar = 100 μm). Right, EM-CCD images of the xiphoid tissue were obtained at 32, 44, and 56 hours post--dexamethasone synchronization (bars = 300 μm). C, Temperature entrainment. Two xiphoid cartilage cultures (represented by red and blue lines) from the same animal were held under antiphase temperature cycles (alternating 12-hour cycles of 38.5°C/36°C; baseline temperature of 37°C). Left, Detrended trace (in counts per minute); shaded area represents enforcement of the temperature protocol. Right, Time of peak circadian expression on day 1 and day 7; CT0 = circadian time 0 (start of recording). On day 7, the 2 cultures had significantly different peak times (*P* = 0.0006 by paired *t*-test). D, Temperature compensation. Left, Representative detrended traces (in counts per second) in cartilage (n = 4) over a 10°C temperature range. Right, Frequency (reaction rate), calculated as 1/period. Temperature coefficient (Q~10~) = 0.9, line of best fit y = −0.00039*x* + 0.05422, R^2^ = 0.68. Results are the mean ± SEM.](art0065-2334-f1){#fig01}

Bioluminescence of the xiphoid tissue was also visualized using a high-sensitivity EM-CCD camera. This revealed rhythmic PER2::luc activity from the cartilaginous tissue ([Figure 1](#fig01){ref-type="fig"}B) (see also Supplementary Video, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract>). There were no differences in the clock properties between the femoral head cartilage and the xiphoid cartilage (mean ± SD period 24.18 ± 0.3 hours and 23.4 ± 0.5 hours, respectively; *P* = 0.2 by *t*-test). Microdissected articular cartilage from the knee joints of adult PER2::luc mice also demonstrated circadian oscillations (results available from the corresponding author upon request). However, the small tissue size meant that cultures did not produce robust enough rhythms for further study. Therefore, xiphoid tissue was used as a convenient and more amenable model in subsequent studies.

Because cartilage is avascular, with no direct innervation, we hypothesized that body temperature oscillations controlled by the central brain clock could be important in entraining local rhythms in this tissue. Indeed, when PER2::luc mouse cartilage was incubated under alternating 12-hour temperature cycles of 38.5°C/36°C, oscillation amplitude was induced ([Figure 1](#fig01){ref-type="fig"}C). Incubating cultures of cartilage tissue from the same animal under antiphase temperature cycles drove the tissue into antiphase ([Figure 1](#fig01){ref-type="fig"}C). Altered phase was maintained under subsequent conditions of constant temperature, thus demonstrating that the observed effect on the circadian rhythm was a clock-based change rather than a passive response to changes in temperature.

Recent evidence suggests that temperature fluctuations will target circadian clock genes at the transcriptional level ([@b3]--[@b27]). To this end, we lentivirally transduced a human chondrosarcoma cell line with clock promoter luciferase reporters, and then administered single 6-hour pulses of heat (+2.5°C) or cool (−2.5°C). Consistently, we found that the transcriptional levels of *Per2*:luc and *Bmal1*::luc were altered (results available from the corresponding author upon request).

A defining feature of a circadian oscillator is temperature compensation, the maintenance of robust periodicity over a broad temperature range ([@b28]). Indeed, our data demonstrated that the circadian rhythm in cartilage was effectively temperature compensated. The circadian period ranged from 23.5 hours to 26.5 hours over a 10°C temperature range (temperature coefficient Q~10~ = 0.9) ([Figure 1](#fig01){ref-type="fig"}D). Taken together, these findings establish the presence of a temperature-compensated, autonomous circadian clock in cartilage tissue and suggest that this clock senses suprachiasmatic nuclei--driven daily changes in body temperature as one means of maintaining synchrony with the rest of the body.

Impact of aging on the cartilage circadian rhythm
-------------------------------------------------

With aging, systemic circadian rhythms in body temperature and hormone release are altered ([@b29]). This may consequently alter the cartilage clock. To test this, we compared PER2::luc rhythms in cartilage from aged mice (ages 20--24 months) and young adult mice (ages 2--4 months). Although there were no significant changes in the circadian period or phase, oscillation amplitude was significantly reduced (reduction of ∼40%) in aged mouse cartilage ([Figures 2](#fig02){ref-type="fig"}A--C). Interestingly, upon dexamethasone treatment, robust rhythmicity was reinitiated to a similar extent (increase of ∼5--10--fold) in both aged and young adult mouse cartilage tissue ([Figure 2](#fig02){ref-type="fig"}D), indicating that intrinsic pacemaking mechanisms within aged cartilage may still be intact. These studies provide evidence that the circadian rhythm in cartilage loses its robustness with advanced age.

![A less robust circadian clock in mouse cartilage during aging. A, Representative traces of PER2::luc bioluminescence from xiphoid cartilage of young adult mice (ages 3--4 months; n = 7) and aged mice (ages 20--24 months; n = 9). Arrow indicates time of treatment with 100 n*M* dexamethasone (Dex) (n = 4 young mice, n = 3 aged mice). B, Oscillation amplitude (left) and circadian period (right) in cartilage tissue from aged mice compared to young mice. ∗ = *P* = 0.015 by *t*-test. NS = not significant. C, Circadian phase at the time between 12-hour cull and the first peak of bioluminescence in culture. Vertical lines represent the mean for each group (*P* = 0.46). D, Similar extent of induction of oscillation amplitude by dexamethasone treatment in young and aged mouse cartilage tissue; amplitude is expressed as a percentage of the amplitude of the young tissue before treatment. Results are the mean ± SEM. Data were analyzed by two-way analysis of variance. There were no significant effects of age group (*P* = 0.77), and interactions were not significantly different (*P* = 0.9992). ∗∗ = *P* = 0.003.](art0065-2334-f2){#fig02}

Identification of the circadian transcriptome in cartilage
----------------------------------------------------------

To gain insight into the function of the circadian clock in cartilage, we aimed to identify its tissue-specific targets. To this end, we performed a time-series microarray using xiphoid tissue from mice kept in constant darkness. This eliminated the effect of the light/dark cycle, and allowed us to reveal endogenously circadian genes. Time points were every 4 hours for 40 hours. To identify circadian transcripts, we used 2 well-recognized algorithms based on different statistical models. With use of the CircWave Batch algorithm, we identified 896 genes oscillating with a period of ∼24 hours (q \< 0.1). Parallel analysis was performed using the JTKCycle method ([@b21]), which identified 1,574 rhythmic genes with a 20--28-hour period (adjusted *P* \< 0.05). To be stringent, we considered only those genes identified by both methods as circadian. Thus, we identified 615 genes with rhythmic expression and a circadian period of ∼24 hours (3.9% of expressed genes, represented by 704 probes) ([Figure 3](#fig03){ref-type="fig"}A and Supplementary Table 1, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract>).

![Identification of the circadian transcriptome in mouse cartilage. A, Heat map depicting the expression level of the 615 circadian genes (represented by 705 probe sets), showing that 3.9% of the cartilage transcriptome is circadian, as identified using CircWave Batch (local false discovery rate \< 0.1, equivalent to approximate R^2^ \> 0.7) and JTKCycle (Bonferroni-adjusted *P* \< 0.05). Genes are organized according to timing of peak expression. B, Clustering and identification of periodic functions. Each panel represents a single cluster, with normalized log-expression levels marked as connected points for each gene over time. Colored lines represent the inferred cluster-wise periodic function, with 2 standard deviations marked by the shaded area. Clusters fall into 4 broad categories, based on the time of peak expression. In A and B, gray-shaded bars represent subjective day, and solid black bars represent subjective night. C, Tissue specificity of cartilage clock-controlled genes. Venn diagram shows a comparison of cartilage circadian genes with previously published gene lists from studies of the liver and skeletal muscle of mice. The total number of genes identified as circadian in each tissue is shown in parentheses; areas of overlap indicate common genes.](art0065-2334-f3){#fig03}

Rhythmic cartilage genes were clustered according to their inferred periodic functions, determined using a Gaussian process model. Genes fell into 11 distinct clusters, which were grouped into 4 categories based on the phase of their peak expression ([Figure 3](#fig03){ref-type="fig"}B). Most genes peaked during subjective daytime ([Figure 3](#fig03){ref-type="fig"}A and results available from the corresponding author upon request). Functional annotation and gene ontology (GO)--term analysis using DAVID revealed several overrepresented functional groups (a full list is available from the corresponding author upon request), with the top overrepresented groups being "purine/ATP binding," "circadian rhythm," "extracellular matrix location/microfibril," "negative regulator of (macromolecule) biosynthetic processes," "proteolysis," and "apoptosis." Interestingly, 81.3% of genes related to "negative regulation of biosynthesis" and 78.6% of genes related to "proteolysis" peaked during the animals\' resting phase (results available from the corresponding author upon request).

We compared our gene list to published sequential chromatin immunoprecipitation assay data on the expression of circadian clock transcription factor *Bmal1* in the liver ([@b30]), and we found that 132 of our rhythmic genes had previously determined *Bmal1* binding sites (see Supplementary Table 1, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/doi/10.1002/art.38035/abstract>). Only 19 circadian genes were common ([Figure 3](#fig03){ref-type="fig"}C) between our gene expression data set from mouse cartilage and previously published data from the liver ([@b31]) and skeletal muscle ([@b32]) of mice, most of which were core clock genes, supporting the concept of tissue-specific clock function.

The expression profiles of canonical clock genes (*Bmal1*, *Per2, Cry1, Nr1d1, Dbp*, and *E4bp4*) and selected cartilage genes (*Adamts4, Adamts9*, and *Mmp14*) were validated by temporal qRT-PCR in mouse xiphoid tissue ([Figure 4](#fig04){ref-type="fig"}A). To confirm the importance of the molecular clock in controlling cartilage gene rhythmicity, we used *ClockΔ19* mutant mice on a PER2::luc background. The expression and behavior of genes in *ClockΔ19* mice are known to be arrhythmic ([@b18]). We established that PER2::luc rhythmicity was lost in the mutant mouse cartilage, and that time-dependent expression of the circadian output genes *Dbp* and *E4bp4* was abolished ([Figure 4](#fig04){ref-type="fig"}B). Importantly, time-dependent expression of the cartilage genes *Adamts4* and *Mmp14* was similarly abolished in the *ClockΔ19* mouse cartilage ([Figure 4](#fig04){ref-type="fig"}B), supporting the conclusion that these genes are clock-controlled.

![Validation of circadian genes in mouse cartilage. A, Relative expression of a panel of clock genes and putative clock-controlled genes in mouse xiphoid tissue, as determined by microarray and validated by quantitative reverse transcription--polymerase chain reaction (qRT-PCR). Data were normalized to the nadir of expression. All genes tested followed the expression pattern identified by the array; when analyzed using one-way analysis of variance, all genes showed significant change with time (*P* \< 0.0001; for *Mmp14*, *P* = 0.0039). Gray-shaded bars denote subjective day, and solid black bars denote subjective night. Results are the mean ± SEM (n = 3 replicates, pooled from 5 animals per replicate). B, Abolition of circadian rhythmicity in *ClockΔ19* mutant animals. Left, Xiphoid tissue cultures from *ClockΔ19* mice on a PER2::luc background showed no molecular rhythmicity, as compared to wild-type (WT) mice, in cultures (results representative of 2 independent experiments; bioluminescence expressed in counts per second). Right, Time-dependent expression of clock output genes was abolished in *ClockΔ19* animals. The qRT-PCR data were normalized to the nadir of expression in WT mice. Results are the mean ± SEM (n = 5). ∗∗ = *P* \< 0.01; ∗∗∗ = *P* \< 0.001, by *t*-test. NS = not significant; ZT = zeitgeber time; ZT0 = lights-on.](art0065-2334-f4){#fig04}

Cell-autonomous circadian rhythms in chondrocytes
-------------------------------------------------

To confirm that chondrocytes harbor cell-autonomous circadian clocks, we isolated immature articular chondrocytes from 5-day-old PER2::luc mice. PMT recording revealed self-sustained circadian oscillations resembling those from the cartilage tissue ([Figure 5](#fig05){ref-type="fig"}A). The mouse cells demonstrated typical morphologic features of chondrocytes, characterized by Alcian blue staining of glycosaminoglycans in the extracellular matrix and high *Col2* expression ([Figure 5](#fig05){ref-type="fig"}B). Furthermore, clock-synchronized primary chondrocytes time-dependently expressed the core clock genes *Nr1d1, Per2, Bmal1,* and *Cry1* ([Figure 5](#fig05){ref-type="fig"}C).

![Cell-autonomous circadian clocks in chondrocytes. A, Representative circadian oscillations of bioluminescence from immature articular chondrocytes isolated from 5-day-old PER2::luc mice (n = 5). B, Confirmation of the chondrocyte phenotype. Left, Cell morphology under phase contrast. Bar = 100 μm. Middle, Alcian blue staining of glycosaminoglycans in the extracellular matrix. Bar = 50 μm. Right, Immunofluorescence for type II collagen (green) with DAPI nuclear counterstain (blue). Bar = 50 μm. C, Time-dependent expression of clock genes in primary chondrocytes. Cells were synchronized and gene expression was assayed by quantitative reverse transcription--polymerase chain reaction (qRT-PCR) at 6-hour intervals. Data were normalized to the nadir of expression. Results are the mean ± SEM (n = 3 technical replicates). *P* \< 0.001 for all genes, by one-way analysis of variance (ANOVA). D, Expression of *Per2*:luc and *Bmal1*:luc reporters in separate cultures of SW-1353 cells after lentiviral delivery. Cells were synchronized by treatment with dexamethasone for 1 hour before bioluminescence recording. Representative detrended traces are shown (mean ± SEM period 24.1 ± 0.3 hours; n = 4). E, Time-dependent expression of cartilage clock targets in human chondrosarcoma cells. Cells were synchronized, and gene expression was assayed by qRT-PCR at 4-hour intervals. Data were normalized to the nadir of expression. Results are the mean ± SEM (n = 4). *P* \< 0.05 for all genes, by one-way ANOVA.](art0065-2334-f5){#fig05}

To test whether human chondrocytes also exhibit circadian rhythmicity, we used lentiviral delivery to stably transduce a human chondrosarcoma cell line (SW-1353) with luciferase reporters driven by promoter fragments of the clock genes *Per2* or *Bmal1*. Both reporters oscillated robustly over several days ([Figure 5](#fig05){ref-type="fig"}D), in antiphase to one another. Similar to that observed in mouse cells, the clock genes *Nr1d1*, *Per2*, and *Bmal1* were time-dependently expressed in SW-1353 cells ([Figure 5](#fig05){ref-type="fig"}E). Interestingly, putative clock target genes (*Adamts4/9*, *Mmp14*, and *Gnl3*) were also expressed in a time-dependent manner ([Figure 5](#fig05){ref-type="fig"}E), although *Adamts4* expression was less robust.

Taken together, these data support the concept that chondrocytes contain a cell-autonomous molecular clock capable of driving downstream targets, extending our findings from a mouse model into human cells. This implies that there is a possible conservation of clock mechanisms in chondrocytes from different species.

Clock gene changes in articular cartilage in an experimental mouse model of OA
------------------------------------------------------------------------------

We next sought to address whether joint articular cartilage expresses clock genes, and whether the expression of clock genes is altered in a surgical DMM model of OA. Laser microdissection allowed us to focus on lesion sites, to study factors initiating damage. One week post-DMM, cartilage tissue damage was minimal; 2 weeks post-DMM, tissue exhibited early focal degeneration; 6 weeks post-DMM, tissue was more extensively damaged, with fibrillation.

Our microarray data set of the gene networks involved in mouse OA is presented elsewhere ([@b26]). We interrogated these data and found that the canonical clock genes *Bmal1*, *E4bp4*, *Nr1d1*, *Per2*, *Cry1*, *Dbp*, and *Rora* were indeed expressed in the DMM articular cartilage. *Bmal1* was expressed at a significantly higher level in DMM cartilage than in sham control cartilage at 1, 2, and 6 weeks post-DMM (*P* \< 0.05) ([Figure 6](#fig06){ref-type="fig"}). The clock output genes *Nr1d1*, *Dbp, Rora,* and *E4bp4* were also significantly altered 2 weeks post-DMM (*P* \< 0.05) ([Figure 6](#fig06){ref-type="fig"}), consistent with the time point at which the greatest change in *Bmal1* expression was observed. Changes in clock gene expression were validated using qRT-PCR (results available from the corresponding author upon request). Taken together, these data indicate that clock gene expression changes early in the progression of experimental OA.

![Deregulation of clock genes in an experimental mouse model of osteoarthritis. Articular cartilage mRNA expression of core clock and clock output genes was determined by microarray analysis. Results of all probes for each gene are shown, with findings expressed as the fold up-regulation or down-regulation of gene expression in joints subjected to destabilization of the medial meniscus (DMM) compared to sham-operated joints in mice at 1, 2, or 6 weeks post--DMM surgery. Values are the mean fold change in 4 mice. The shaded region between +1-fold and −1-fold represents no differential expression. ∗ = adjusted *P* \< 0.05; ∗∗ = adjusted *P* \< 0.01.](art0065-2334-f6){#fig06}

DISCUSSION
==========

Mice with mutations in clock genes show ectopic ossification of tendon and cartilage, altered regulation of bone volume, an increased susceptibility to inflammatory arthritis, and, as recently reported, defects in long bone growth through clock control of chondrocyte differentiation ([@b9]--[@b33]). These studies highlight the potential importance of circadian clocks in the skeletal system. However, to the best of our knowledge, no studies have demonstrated functional and cell-autonomous circadian clocks in fully differentiated cartilage tissue. Therefore, we set out to address the following questions. 1) Do cartilage and chondrocytes contain self-sustained circadian clocks? 2) What factors entrain the cartilage clock? 3) What cartilage-specific genes/pathways are controlled by the circadian clock? 4) How does the cartilage circadian clock change with aging and during the pathogenesis of experimental arthritis?

Herein, we have demonstrated cell-autonomous circadian clocks in cartilage tissue and chondrocytes. Similar to previously described peripheral circadian clocks ([@b3]--[@b28]), the cartilage clock is entrained by temperature cycles approximating body temperature fluctuations and its periodicity is effectively maintained across a wide temperature range. Thus, sensing changes in body temperature may be one way for the cartilage clock to maintain synchronization to the rest of the body. Although chondrocytes are dispersed in the avascular and aneural cartilage, systemic factors freely diffuse and it is probable that multiple entraining factors, such as hormone signaling, act alongside temperature to entrain the clock.

Age is the major risk factor for developing OA. Its precise role in disease pathogenesis is unknown. Disruption to whole-body circadian rhythms through aging could alter systemic time cues and compromise cartilage clock function. Indeed, the results of the present study show that PER2::luc circadian rhythms were dampened in aged mouse cartilage tissue. We speculate that age-associated dampening in circadian rhythms could disrupt downstream OA-associated genes and increase disease susceptibility. Circadian amplitude in aged tissue could be restored to that of young cartilage by treatment with dexamethasone, suggesting that inherent changes in the molecular clock are unlikely. Instead, we hypothesize that age-related dampening of the cartilage clock may be a consequence of altered systemic time cues. This is consistent with a previous report showing no difference in the molecular clock of cultured human fibroblasts between old and young individuals, although their serum had different clock-synchronizing properties ([@b34]). Our data suggest that the aged cartilage clock might be re-tuned by factors strengthening systemic circadian rhythms, such as scheduled exercise ([@b35]), restricted meal times ([@b36]), or the scheduled warming and cooling of joints; this may have significant impact on the future management of joint diseases such as OA.

Peripheral circadian clocks temporally regulate tissue-specific functions through control of downstream CCGs. Indeed, 3--15% of total transcripts are expressed rhythmically, depending on the tissue, sampling frequency, and analysis stringency ([@b31]--[@b37]). Herein, we have identified the first circadian transcriptome profile in cartilage tissue. Our results revealed rhythmic expression of ∼3.9% of all expressed genes, with the majority of the genes being tissue specific. By selecting genes identified by both CircWave and JTKCycle, we generated a relatively conservative circadian gene list. However, it is likely that some of the genes identified are directly responsive to time cues, such as body temperature, rather than being local clock driven. Studies in other tissues ([@b38]--[@b39]) have demonstrated only a small number of such system-driven genes (10--16%). Indeed, we demonstrated cell-autonomous oscillations of clock genes and putative targets in cells lacking systemic time cues.

The rhythmic transcripts identified in cartilage exhibited 11 distinct patterns of expression. We predict that genes within each cluster are coregulated by similar clock proteins and tissue-specific transcription factors. Interestingly, in our mouse cartilage data set, early-day transcripts included several extracellular matrix components (fibrillins, laminin, collagens, and netrin), and almost one-half of the rhythmic proteolysis genes peaked at this early-day time point. Restricting genes controlling macromolecule turnover to the resting phase may confer a selective advantage, allowing more effective tissue remodeling and repair following (nocturnal) activity bouts. It is possible that disruption to this time-coordinated homeostasis during aging increases OA susceptibility.

Disruptions in several of the rhythmic genes/pathways identified herein have previously been linked to joint diseases ([@b40]--[@b44]). These include genes involved in catabolic signaling (*Adamts4*, *Adamts9*, and *Mmp14*), anabolic signaling (*Tgfβr3* and *Timp4*), and the oxidative defense pathway (*Gclc* and *Gstm1*), as well as apoptosis-related genes (*Xiap*). Some genes have even been suggested as drug targets, for example, the *Adamts* family of aggrecanases ([@b45]). Interestingly, a newly identified OA susceptibility gene, *Gnl3* ([@b42]), was also rhythmic. The circadian nature of these genes may help inform appropriate targeting strategies, including, for example, timed drug administration (chronotherapy), with the aim of improving efficacy and reducing toxicity ([@b46]). Our study also raises the possibility of targeting the gene activity of chondrocytes through the use of circadian clock--acting compounds ([@b47]--[@b48]), which may prove of use in the treatment of diseases such as OA.

It should be noted that we used xiphoid tissue as a model for mature cartilage in the time series, due to limitations involved in microdissecting articular cartilage, but that both tissues exhibit circadian rhythms (results available from the corresponding author upon request). Furthermore, we demonstrated that both mouse primary chondrocytes and human chondrosarcoma-derived SW-1353 cells rhythmically express clock genes in vitro ([Figure 5](#fig05){ref-type="fig"}), although we recognize that the latter cell line is a limited model for primary cells or tissue ([@b49]).

Results of previous studies have suggested that clock genes change during inflammatory joint disease ([@b11]--[@b15]), but no studies have addressed whether clock genes in articular cartilage change during OA initiation/progression. Herein, we have shown that clock genes are indeed expressed in articular cartilage. Moreover, during the development of OA in a mouse DMM model, the expression of these genes was disrupted. Interestingly, most of the changes were seen during the early stage of the disease (2 weeks post-DMM), not when the disease phenotype was more established (6 weeks post-DMM). This could mean that clock gene changes contribute to the disease phenotype through the disruption of CCGs, rather than being a consequence of tissue damage. Due to technical limitations, we compared expression changes of clock genes at a single daytime time point (10:00 [AM]{.smallcaps}--noon). Future studies with more time points will be required to determine changes in the period or amplitude of these genes.

Taken together, our data provide substantial insight into the circadian regulation of cartilage biologic processes. These results provide a firm base upon which to further explore the link between the circadian clock, aging, cartilage homeostasis, and OA.
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